Matches in SemOpenAlex for { <https://semopenalex.org/work/W4319460740> ?p ?o ?g. }
- W4319460740 endingPage "2363" @default.
- W4319460740 startingPage "2353" @default.
- W4319460740 abstract "Obesity-induced metabolic disorders can cause chronic inflammation in the whole body, activating the nuclear factor kappa B (NF-κB) pathway and inducing apoptosis. Therefore, anti-inflammatory strategies may be effective in preventing obesity-related renal injury. Tabersonine (Tab) has been used pharmacologically to alleviate inflammation-related symptoms. This study evaluated the therapeutic effect of Tab on obesity-related renal injury and explored the pharmacological mechanism. Tab (20 mg/kg) relieved HFD-induced renal structural disorder and alleviated renal functional decline in mice, including improvement of renal tissue fibrosis, reducing renal cell apoptosis and inflammation in renal tissues. Mechanistically, we demonstrated that Tab inhibited the activation of NF-κB signaling pathway both in vivo and in vitro, thereby improving the renal tissue lesions in the mice with obesity-related renal injury. In both the obese mouse model and the mouse glomerular mesangial cell model, the natural compound Tab ameliorated HFD- and saturated fatty acid-induced renal cell injury by inhibiting the activation of NF-κB signaling pathway. Our data suggest that Tab may become a potential candidate for the prevention and treatment of obesity-related renal injury." @default.
- W4319460740 created "2023-02-09" @default.
- W4319460740 creator A5006096480 @default.
- W4319460740 creator A5006444996 @default.
- W4319460740 creator A5030458602 @default.
- W4319460740 creator A5037987563 @default.
- W4319460740 creator A5038255186 @default.
- W4319460740 creator A5039713279 @default.
- W4319460740 creator A5040034080 @default.
- W4319460740 creator A5046295943 @default.
- W4319460740 creator A5046628035 @default.
- W4319460740 creator A5064710862 @default.
- W4319460740 creator A5079228450 @default.
- W4319460740 date "2023-02-08" @default.
- W4319460740 modified "2023-10-17" @default.
- W4319460740 title "Tabersonine attenuates obesity‐induced renal injury via inhibiting <scp>NF‐κB</scp>‐mediated inflammation" @default.
- W4319460740 cites W2016366089 @default.
- W4319460740 cites W2043067806 @default.
- W4319460740 cites W2048148270 @default.
- W4319460740 cites W2107925903 @default.
- W4319460740 cites W2144535719 @default.
- W4319460740 cites W2160517419 @default.
- W4319460740 cites W2195252126 @default.
- W4319460740 cites W2512845699 @default.
- W4319460740 cites W2560569403 @default.
- W4319460740 cites W2604643770 @default.
- W4319460740 cites W2623056842 @default.
- W4319460740 cites W2794151106 @default.
- W4319460740 cites W2801210045 @default.
- W4319460740 cites W2806362065 @default.
- W4319460740 cites W2888812846 @default.
- W4319460740 cites W2896675733 @default.
- W4319460740 cites W2913590717 @default.
- W4319460740 cites W2968513998 @default.
- W4319460740 cites W2971140433 @default.
- W4319460740 cites W2989088346 @default.
- W4319460740 cites W2995414145 @default.
- W4319460740 cites W3010810592 @default.
- W4319460740 cites W3015068556 @default.
- W4319460740 cites W3017114516 @default.
- W4319460740 cites W3021867869 @default.
- W4319460740 cites W3026172159 @default.
- W4319460740 cites W3035710590 @default.
- W4319460740 cites W3047649393 @default.
- W4319460740 cites W3085470662 @default.
- W4319460740 cites W3093171001 @default.
- W4319460740 cites W3099453602 @default.
- W4319460740 cites W3124393267 @default.
- W4319460740 cites W3133032876 @default.
- W4319460740 cites W3134953774 @default.
- W4319460740 cites W3135055431 @default.
- W4319460740 cites W3162068390 @default.
- W4319460740 cites W3190882230 @default.
- W4319460740 cites W3195813565 @default.
- W4319460740 cites W3198507355 @default.
- W4319460740 cites W3217572672 @default.
- W4319460740 cites W4200108436 @default.
- W4319460740 cites W4200447830 @default.
- W4319460740 cites W4205943199 @default.
- W4319460740 cites W4213210446 @default.
- W4319460740 cites W4214587353 @default.
- W4319460740 cites W4221068733 @default.
- W4319460740 cites W4224236056 @default.
- W4319460740 cites W4224304820 @default.
- W4319460740 cites W4225085239 @default.
- W4319460740 cites W4281702237 @default.
- W4319460740 cites W4281705658 @default.
- W4319460740 cites W4282979306 @default.
- W4319460740 doi "https://doi.org/10.1002/ptr.7756" @default.
- W4319460740 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36752025" @default.
- W4319460740 hasPublicationYear "2023" @default.
- W4319460740 type Work @default.
- W4319460740 citedByCount "0" @default.
- W4319460740 crossrefType "journal-article" @default.
- W4319460740 hasAuthorship W4319460740A5006096480 @default.
- W4319460740 hasAuthorship W4319460740A5006444996 @default.
- W4319460740 hasAuthorship W4319460740A5030458602 @default.
- W4319460740 hasAuthorship W4319460740A5037987563 @default.
- W4319460740 hasAuthorship W4319460740A5038255186 @default.
- W4319460740 hasAuthorship W4319460740A5039713279 @default.
- W4319460740 hasAuthorship W4319460740A5040034080 @default.
- W4319460740 hasAuthorship W4319460740A5046295943 @default.
- W4319460740 hasAuthorship W4319460740A5046628035 @default.
- W4319460740 hasAuthorship W4319460740A5064710862 @default.
- W4319460740 hasAuthorship W4319460740A5079228450 @default.
- W4319460740 hasConcept C126322002 @default.
- W4319460740 hasConcept C134018914 @default.
- W4319460740 hasConcept C185592680 @default.
- W4319460740 hasConcept C190283241 @default.
- W4319460740 hasConcept C2776914184 @default.
- W4319460740 hasConcept C2777730290 @default.
- W4319460740 hasConcept C2778653478 @default.
- W4319460740 hasConcept C2780091579 @default.
- W4319460740 hasConcept C2780472472 @default.
- W4319460740 hasConcept C2780559512 @default.
- W4319460740 hasConcept C55493867 @default.
- W4319460740 hasConcept C71924100 @default.
- W4319460740 hasConcept C98274493 @default.